Release Date: December 15, 2023
Expiration Date: December 15, 2024
Activity Overview
This online, on-demand virtual symposium brings together renowned experts in NSCLC. In this educational program, these experts share clinical insights and advances in the management of early-stage disease with surgery and novel neoadjuvant, adjuvant, and perioperative immunotherapy-based approaches.
This educational activity is an archive of the live symposium held on November 29, 2023.
Target Audience
These activities are intended for oncologists and other oncology health care professionals interested in the latest advances in the diagnosis, treatment, and management of lung cancer.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Discuss the rationale for applying immunotherapeutic strategies to early-stage and locally advanced NSCLC settings, as well as key considerations in multidisciplinary care coordination between thoracic surgeons, medical oncologists, radiologists, and radiation oncologists
- Design personalized care strategies to integrate evidence with evolving immunotherapy-based approaches to manage patients with resectable stage I-III NSCLC
- Analyze recent data and emerging trends utilizing immune checkpoint inhibitor-based strategies for the management of patients with unresectable stage III NSCLC
- Apply interdisciplinary care strategies for the management of stage I-III NSCLC that include methods to monitor for, identify, and mitigate the impact of irAEs
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
